For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

Inivata Ltd.

USPTO Granted Patents = 19

EPO Patents = 4

Trademarks = 8

Forward Citations = 19

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Tim Forshew (15 out of 15 patents)

Samuel Woodhouse (14 out of 17 patents)

Vincent Plagnol (12 out of 12 patents)

4. Stefanie Viola Lensing (11 out of 11 patents)

5. Matthew Edward Smith (6 out of 6 patents)

6. Karen Howarth (3 out of 3 patents)

7. Michael Epstein (3 out of 3 patents)

8. Giovanni Marsico (3 out of 3 patents)

9. Andrew Lawson (3 out of 3 patents)

10. Clive Morris (2 out of 2 patents)

11. John Beeler (2 out of 2 patents)

12. Greg Jones (2 out of 2 patents)

19 patents: Sort by Forward Citations

1. 12516370 - METHODS FOR LABELLING NUCLEIC ACIDS (2026-01-06),

2. 12509733 - Methods and systems for detecting a primary disease (2025-12-30),

3. 12378595 - Method for the analysis of minimal residual disease (2025-08-05),

4. 12371744 - Method of sequencing a nucleic acid of interest (2025-07-29),

5. 12365940 - Methods of labelling nucleic acids using variable length oligonucleotides (2025-07-22),

6. 12247249 - Method for amplifying a genomic sample (2025-03-11),

7. 12195807 - Method of treating a cancer patient without the need for a tissue biopsy (2025-01-14),

8. 12163187 - Methods of sequencing nucleic acids and error correction of sequence reads (2024-12-10),

9. 12084724 - Computational method for detecting fusion events (2024-09-10),

10. 11788116 - Method for the analysis of minimal residual disease (2023-10-17),

11. 11674175 - Methods of labelling nucleic acids (2023-06-13),

12. 11566274 - Method for the analysis of minimal residual disease (2023-01-31),

13. 11377698 - Method of treating a cancer patient without the need for a tissue biopsy (2022-07-05),

14. 11359233 - Methods for labelling nucleic acids (2022-06-14),

15. 11186878 - Method for predicting and monitoring response to an immune checkpoint inhibitor (2021-11-30),

Inivata is a pioneering, clinical genomics company utilizing a liquid biopsy approach to transform cancer care. Their innovative InVision® platform detects cancer mutations in the blood, offering a non-invasive and real-time method for monitoring and guiding treatment. Inivata is committed to advancing precision medicine through cutting-edge technology and translational research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

19 Patents

#57 in Cambridge

#924 in United Kingdom

#32,555 in the World

Cambridge, United Kingdom

Inivata Ltd.

Forward Citations = 19

12 inventors:

Tim Forshew (15 out of 15 patents)

Samuel Woodhouse (14 out of 17 patents)

Vincent Plagnol (12 out of 12 patents)

4. Stefanie Viola Lensing (11 out of 11 patents)

5. Matthew Edward Smith (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…